Search

Your search keyword '"Shaw E.G."' showing total 83 results

Search Constraints

Start Over You searched for: Author "Shaw E.G." Remove constraint Author: "Shaw E.G."
83 results on '"Shaw E.G."'

Search Results

1. TRAIT (Treatment-Related Alterations in Thinking): A Prospective Longitudinal Study Assessing Mild Cognitive Impairment in Irradiated Brain Tumor Patients

2. A Mutation and Prognostic Biomarker Study in Grade II and III Gliomas Utilizing a Combined Cohort of NRG Oncology/RTOG 9802 and 9813

3. Late Breast Toxicity Rates in a Prospective Evaluation of Radiation Therapy (RT) in a Multiracial/Ethnic Population of Breast Cancer (BC) Patients

4. Oxidative DNA Damage in Radiation Therapy Related Early Adverse Skin Reactions in Breast Cancer

5. L-arginine–Based Nutritional Supplement Did Not Improve Erectile Function or Quality of Life in Prostate Cancer Survivors Previously Treated With Radiation Therapy: Results of CCOP Research Base Protocol 98110 – A Randomized Phase 2 Dose Finding Study

6. Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG)

25. 148

26. 2060

27. The Outcome of Gamma Knife Radiosurgery for Facial Pain Varies by Pre-treatment Burchiel Classification Pain Type: Results From 256 Gamma Knife Radiosurgery Procedures for Facial Pain

28. A Phase III, Double Blind, Placebo-Controlled, Prospective Randomized Trial on the Effect of Megestrol Acetate on Weight and Health Related Quality of Life in Lung Cancer and Head and Neck Cancer Patients Receiving Curative Radiation Therapy

37. 101 The impact of surgical adjuvant thoracic radiation therapy for non-small cell lung cancer patients with mediastinal nodal involvement

43. Neurotoxicity of radiosurgery

44. Reclamation work under unfavourable natural conditions.

49. Clinical Endpoints Correlation with Molecular Features in the NRG Oncology/RTOG 9802 Low-Grade Glioma, Low-Risk Observation Arm.

50. Comprehensive Prognostic and Predictive Molecular Subgroup Analysis within the High-risk Treatment Arms of NRG Oncology/RTOG 9802: a Phase III Trial of RT versus RT + PCV in High-risk Low-grade Gliomas.

Catalog

Books, media, physical & digital resources